4:57
Open-label extension study of lecanemab in early Alzheimer’s disease
Chad Swanson
• 26 Apr 2021
0:45
Impact of fcRn inhibitors on IgG-mediated autoimmune disorders
James F. Howard Jr.
• 7 Apr 2021